JP2013511728A - 癌のバイオマーカー - Google Patents

癌のバイオマーカー Download PDF

Info

Publication number
JP2013511728A
JP2013511728A JP2012540089A JP2012540089A JP2013511728A JP 2013511728 A JP2013511728 A JP 2013511728A JP 2012540089 A JP2012540089 A JP 2012540089A JP 2012540089 A JP2012540089 A JP 2012540089A JP 2013511728 A JP2013511728 A JP 2013511728A
Authority
JP
Japan
Prior art keywords
cancer
tumor
ovarian cancer
subject
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012540089A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013511728A5 (https=
Inventor
タイラー，ダグラス，ディー．
ガーセル−タイラー，シセク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Louisville Research Foundation ULRF
Original Assignee
University of Louisville Research Foundation ULRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Louisville Research Foundation ULRF filed Critical University of Louisville Research Foundation ULRF
Publication of JP2013511728A publication Critical patent/JP2013511728A/ja
Publication of JP2013511728A5 publication Critical patent/JP2013511728A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2012540089A 2009-11-20 2010-11-19 癌のバイオマーカー Pending JP2013511728A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26323509P 2009-11-20 2009-11-20
US61/263,235 2009-11-20
PCT/US2010/057427 WO2011063232A1 (en) 2009-11-20 2010-11-19 Biomarkers of cancer

Publications (2)

Publication Number Publication Date
JP2013511728A true JP2013511728A (ja) 2013-04-04
JP2013511728A5 JP2013511728A5 (https=) 2014-01-16

Family

ID=44060024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012540089A Pending JP2013511728A (ja) 2009-11-20 2010-11-19 癌のバイオマーカー

Country Status (6)

Country Link
US (1) US20150005187A1 (https=)
EP (1) EP2501845A4 (https=)
JP (1) JP2013511728A (https=)
AU (1) AU2010321787B2 (https=)
CA (1) CA2781408A1 (https=)
WO (1) WO2011063232A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016507748A (ja) * 2013-01-31 2016-03-10 アリゾナ ボード オブ リージェンツ， ア ボディー コーポレイト オブ ザ ステート オブ アリゾナ， アクティング フォー アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティー 卵巣癌の早期発見のための自己抗体サイン
JP2018517892A (ja) * 2015-04-10 2018-07-05 アプライド プロテオミクス，インク． 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル
JP2023545012A (ja) * 2020-10-05 2023-10-26 フリーノム ホールディングス，インク． 結腸細胞増殖性障害を早期発見するためのマーカー

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102393458B (zh) * 2011-08-24 2013-12-18 绍兴市人民医院 一种早期乳腺癌血清诊断试剂
US20140186293A1 (en) * 2012-12-31 2014-07-03 University Of Louisville Research Foundation, Inc. Immunoglobulin-bound extracellular vesicles and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007322211A (ja) * 2006-05-31 2007-12-13 Green Peptide Co Ltd がん患者の予後予測方法
JP2008501332A (ja) * 2004-06-02 2008-01-24 ダイアゲニック エイエス 癌診断のためのオリゴヌクレオチド
WO2008092164A2 (en) * 2007-01-26 2008-07-31 University Of Louisville Research Foundation, Inc. Methods of detecting autoantibodies for diagnosing and characterizing disorders
US20110028343A1 (en) * 2008-04-01 2011-02-03 The Brigham And Women's Hospital, Inc. Biomarkers of Ovarian Cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780161B1 (fr) 1998-06-17 2000-09-29 Centre Nat Rech Scient Procede de diagnostic precoce du cancer base sur la recherche d'auto-anticorps diriges contre la proteine csk et trousse pour sa mise en oeuvre
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
US20030119079A1 (en) 2001-09-19 2003-06-26 The Regents Of The University Of Michigan Detection and treatment of cancers of the breast
WO2003026494A2 (en) * 2001-09-28 2003-04-03 Sidney Kimmel Cancer Center Galectins-1-and-4 in tumor development
US20050158737A1 (en) * 2002-03-27 2005-07-21 Alison Banham Tumour associated antigens

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008501332A (ja) * 2004-06-02 2008-01-24 ダイアゲニック エイエス 癌診断のためのオリゴヌクレオチド
JP2007322211A (ja) * 2006-05-31 2007-12-13 Green Peptide Co Ltd がん患者の予後予測方法
WO2008092164A2 (en) * 2007-01-26 2008-07-31 University Of Louisville Research Foundation, Inc. Methods of detecting autoantibodies for diagnosing and characterizing disorders
US20110028343A1 (en) * 2008-04-01 2011-02-03 The Brigham And Women's Hospital, Inc. Biomarkers of Ovarian Cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN5013000645; ＳＯＩＦＦＥＲ: 'ＲＥＣＯＭＢＩＮＡＮＴ　ＩＮＴＥＲＬＥＵＫＩＮ-２　ＩＮＦＵＳＩＯＮＳ　ＡＮＤ　ＤＥＣＲＥＡＳＥＤ　ＩＧＧ２　ＳＵＢＣＬＡＳＳ　ＣＯＮＣＥＮＴＲＡＴＩＯＮＳ' ＢＬＯＯＤ Ｖ８５, 1995, Ｐ９２５-９２８ *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016507748A (ja) * 2013-01-31 2016-03-10 アリゾナ ボード オブ リージェンツ， ア ボディー コーポレイト オブ ザ ステート オブ アリゾナ， アクティング フォー アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティー 卵巣癌の早期発見のための自己抗体サイン
JP2018517892A (ja) * 2015-04-10 2018-07-05 アプライド プロテオミクス，インク． 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル
JP2023545012A (ja) * 2020-10-05 2023-10-26 フリーノム ホールディングス，インク． 結腸細胞増殖性障害を早期発見するためのマーカー

Also Published As

Publication number Publication date
EP2501845A1 (en) 2012-09-26
EP2501845A4 (en) 2013-04-24
AU2010321787A1 (en) 2012-06-14
WO2011063232A1 (en) 2011-05-26
CA2781408A1 (en) 2011-05-26
US20150005187A1 (en) 2015-01-01
AU2010321787B2 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
Caron et al. Cancer immunomics using autoantibody signatures for biomarker discovery
US20120100558A1 (en) Lung cancer diagnosis
US8772038B2 (en) Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast
EP1775590A1 (en) Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
EP3545309B1 (en) Antibody assay
EP2457092B1 (en) Cancer biomarker and the use thereof
ES3054089T3 (en) Novel stool-based protein biomarkers for colorectal cancer screening
CA2453580A1 (en) Detection of ovarian cancer based upon alpha-haptoglobin levels
Liu et al. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer
Patwa et al. The identification of phosphoglycerate kinase‐1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray
US20150005187A1 (en) Biomarkers of Cancer
WO2013106913A1 (en) Biomarkers for breast cancer prognosis and treatment
CN115877006B (zh) 卵巢癌相关的生物标志物及其应用
KR20150137118A (ko) 전립선암의 바이오마커 검출에서 사용하기 위한 방법 및 어레이
US20120277326A1 (en) Biomarkers of cancer
KR20230165283A (ko) 암을 위한 바이오마커 및 요법 표적으로서의 시트룰린화된 단백질
Taylor et al. Characterization of humoral responses of ovarian cancer patients: Antibody subclasses and antigenic components
Devine et al. Predictive value of the combination of serum markers, CAI 25, CASA and TPS in ovarian cancer
EP2115473B1 (en) Markers for transformed epithelium and potential targets for therapy of cancer of the gingivo buccal complex
US20160291022A1 (en) Olfactomedin-4, Neudesin and Desmoplakin as Biomarkers of Breast Cancer
Lee CA215, a new pan cancer biomarker, and its clinical applications
Beretov Proteomics investigation of breast cancer biomarkers in urine and blood for diagnosis and monitoring
Soheimi Proteomic Analysis of Urinary Proteins from Patients with Ovarian Cancer and Cervical Cancer
Abdullah Soheimi Proteomic analysis of urinary proteins from patients with ovarian cancer and cervical cancer/Siti Suhana Binti Abdullah Soheimi
Streckfus Salivary diagnostics: a new solution for an old problem: breast cancer detection

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131119

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140611

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140617

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140917

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140925

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150526

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150826

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160202

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160906